Brief: Aridis Pharmaceuticals Announces $25 Mln Registered Direct Offering Priced At Premium To Market
02/08/2021 13:01
Aug 2 (Reuters) - Aridis Pharmaceuticals Inc ARDS.O :
* ARIDIS PHARMACEUTICALS ANNOUNCES $25 MILLION REGISTERED
DIRECT
OFFERING PRICED AT A PREMIUM TO MARKET
Source text for Eikon: ID:nPn7Mn2ZBa
Further company coverage: ARDS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aridis Pharmaceuticals
See all newsBrief: Aridis Pharmaceuticals Inc - On September 7 Nasdaq Announced That It Would Delist Common Stock Of Co
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle
U.S. STOCKS ON THE MOVE-Pinterest, Sunrun, Tencent Music